Nuacht
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...
Paxton's office said the company supplied free nurses to help care for patients who received its drugs, as well as ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
6 uair an chloigon MSN
One in four US adults with diabetes used a GLP-1 drug last year, survey finds
More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" ...
Texas Attorney General Ken Paxton claims that through an alleged kickback scheme Eli Lilly “fraudulently sought to maximize profits at taxpayer expense.” ...
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly, alleging the pharmaceutical giant engaged in bribery ...
16 uair an chloigon MSN
Popular weight-loss drugs linked to sudden vision loss, research suggests
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Tá torthaí a d'fhéadfadh a bheith dorochtana agat á dtaispeáint faoi láthair.
Folaigh torthaí dorochtana